Science

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

chibe.upenn.edu

Dec 20, 2024, 14:19

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

Ravi Parikh, Director of Human-Algorithm Collaboration Lab at Winship Cancer Institute of Emory University, shared a post on X about a recent paper by him and colleagues published in JCO Clinical Cancer Informatics:

“Check out our JCO Clinical Cancer Informatics paper on the development and real-world/clinical trial validation of Deep Learning CT biomarker to predict immunotherapy response in non-small cell lung cancer! Presented at ASCO24.”

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer

Authors: Chiharu Sako et al.

More posts featuring Ravi Parikh.

ASCO24 cancer Chiharu Sako Chong Duan George Simon Hugo Aerts JCO Clinical Cancer Informatics Kevin Maresca non small cell lung cancer NSCLC OncoDaily Oncology Petr Jordan Ravi Parikh Sean Kent Taly Gilat Schmidt

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage